Our perspectives on aortic stenosis (AS) are changing. Evolving from the traditional thought
of a passive degenerative disease, developing a greater understanding of the condition's …

Objectives The management of severe aortic stenosis mandates consideration of aortic
valve intervention for symptomatic patients. However, for asymptomatic patients with severe …

Aims Left ventricular remodelling occurs during the chronic course of aortic regurgitation
(AR) and aortic stenosis (AS), leading to myocardial hypertrophy and fibrosis. Several …

Aim Cardiac remodelling plays a major role in the prognosis of patients with aortic stenosis
(AS) and could impact the benefits of aortic valve replacement. Our study aimed to evaluate …

Aortic stenosis (AS) is the most frequent valvular heart disease among the older individuals.
Current guidelines indicate intervention for patients with symptomatic or fast progressive …

Mixed aortic stenosis (AS) and aortic regurgitation (AR) is the most frequent concomitant
valve disease worldwide and represents a heterogeneous population ranging from mild AS …

Recognizing symptoms in elderly patients with severe aortic stenosis (AS) can be a
challenge. Serum biomarkers such as Galectin-3 or N-terminal prohormone B-type …

Patients with severe aortic valve stenosis and concomitant pulmonary hypertension show a
significantly reduced survival prognosis. Right heart catheterization as a preoperative …

Background Aortic stenosis (AS) is one of the most common cardiac diseases and major
cause of morbidity and mortality in the elderly. Transcatheter aortic valve implantation (TAVI) …

Currently, the symptomatic status and left ventricular ejection fraction (LVEF) play a crucial
role in aortic stenosis (AS) assessment. However, the symptoms are often subjective, and …